全文获取类型
收费全文 | 689篇 |
免费 | 40篇 |
国内免费 | 2篇 |
专业分类
林业 | 41篇 |
农学 | 13篇 |
基础科学 | 5篇 |
57篇 | |
综合类 | 113篇 |
农作物 | 17篇 |
水产渔业 | 41篇 |
畜牧兽医 | 393篇 |
园艺 | 11篇 |
植物保护 | 40篇 |
出版年
2023年 | 6篇 |
2022年 | 6篇 |
2021年 | 8篇 |
2020年 | 13篇 |
2019年 | 9篇 |
2018年 | 15篇 |
2017年 | 20篇 |
2016年 | 22篇 |
2015年 | 5篇 |
2014年 | 32篇 |
2013年 | 37篇 |
2012年 | 18篇 |
2011年 | 26篇 |
2010年 | 25篇 |
2009年 | 24篇 |
2008年 | 20篇 |
2007年 | 20篇 |
2006年 | 29篇 |
2005年 | 27篇 |
2004年 | 33篇 |
2003年 | 25篇 |
2002年 | 18篇 |
2001年 | 13篇 |
2000年 | 16篇 |
1999年 | 14篇 |
1998年 | 17篇 |
1997年 | 16篇 |
1996年 | 18篇 |
1995年 | 17篇 |
1994年 | 5篇 |
1993年 | 6篇 |
1992年 | 11篇 |
1991年 | 6篇 |
1990年 | 7篇 |
1989年 | 8篇 |
1988年 | 15篇 |
1986年 | 10篇 |
1985年 | 7篇 |
1984年 | 5篇 |
1983年 | 8篇 |
1982年 | 4篇 |
1981年 | 4篇 |
1980年 | 4篇 |
1978年 | 4篇 |
1977年 | 4篇 |
1974年 | 4篇 |
1973年 | 5篇 |
1972年 | 4篇 |
1968年 | 4篇 |
1948年 | 9篇 |
排序方式: 共有731条查询结果,搜索用时 15 毫秒
161.
162.
163.
Extension of beef cattle genetic evaluation procedures to multibreed data sets is proposed as a way to allow inclusion of crossbred animals into current analyses and to provide comparisons between purebred animals of different breeds. Previous papers dealing with multibreed BLUP have proposed sire or sire-maternal grandsire models. Because current models used in the beef industry are predominantly of the reduced animal model form, models were developed for animal model and reduced animal model mixed-model evaluations that would account for fixed and random additive genetic effects, along with fixed and random nonadditive genetic effects for populations with heterogeneous means and variances. 相似文献
164.
Promastigote Leishmania-organisms were diagnostically cultivated in vitro from popliteal lymph node aspirates obtained from 32 of in total 36 dogs returning from endemic areas. Isoenzyme analysis (glucosephosphate-isomerase (GPI), phosphoglucomutase (PGM) and glutamate-oxaloacetate-transaminase (GOT) resulted in the identification of Leishmania infantum (syn. Leishmania (L.) infantum) for all 18 isolates investigated. Parasites were still able to be cultivated in vitro in 79% of 28 biopsies (from 15 dogs) even following chemotherapy by Glucantime, independent of the time of sampling and the course of disease after treatment. Dogs with a progressive form of disease (despite chemotherapy) showed only a minor or no reduction (between 0 and 4.8%) of the relative antibody concentration (determined by ELISA), whereas regressive forms of disease (without recurrences observed in the period of 10 to 37 months after therapy) demonstrated a marked reduction of the relative antibody concentration (between 6.7 and 16.2%) within the first 5 to 8 months; thereafter the decrease diminished and changed to a persistent low relative antibody concentration. 相似文献
165.
Two vaccines, based on formalin-killed whole cells of toxigenic Pasteurella multocida type D and Bordetella bronchiseptica combined with a partially toxoided cell extract of P multocida, were prepared with Freund's incomplete adjuvant (vaccine 1) or by alum precipitation (vaccine 2). Each was tested for safety and efficacy in reducing the severity of nasal turbinate atrophy and improving the growth rate of pigs in three Western Australian commercial piggeries with endemic atrophic rhinitis. In safety experiments with vaccine 1, no adverse clinical effects were observed in vaccinated sows or their progeny. Piglets receiving vaccine 2 showed no injection site abnormalities, pyrexia or turbinate atrophy. In field trials, vaccine 1 significantly reduced the prevalence of moderate to severe nasal turbinate atrophy (Done score 3 to 5) when used in two piggeries (A and B). Progeny from vaccinated sows in piggery B also grew significantly faster than controls. When vaccine 2 was used in piggery A at a later date and in another piggery (C), growth rate was not improved in either piggery and the prevalence of moderate to severe turbinate atrophy was reduced only in piggery C. 相似文献
166.
With the commercial release in Australia in 2004 of a vaccine against feline immunodeficiency virus (FIV; Fel‐O‐Vax FIV®), the landscape for FIV diagnostics shifted substantially. Point‐of‐care (PoC) antibody detection kits, which had been the mainstay for diagnosing FIV infection since the early 1990s, were no longer considered accurate to use in FIV‐vaccinated cats, because of the production of vaccine‐induced antibodies that were considered indistinguishable from those produced in natural FIV infections. Consequently, attention shifted to alternative diagnostic methods such as nucleic acid detection. However, over the past 5 years we have published a series of studies emphasising that FIV PoC test kits vary in their methodology, resulting in differing accuracy in FIV‐vaccinated cats. Importantly, we demonstrated that two commercially available FIV antibody test kits (Witness? and Anigen Rapid?) were able to accurately distinguish between FIV‐vaccinated and FIV‐infected cats, concluding that testing with either kit offers an alternative to PCR testing. This review summarises pertinent findings from our work published in a variety of peer‐reviewed research journals to inform veterinarians (particularly veterinarians in Australia, New Zealand and Japan, where the FIV vaccine is currently commercially available) about how the approach to the diagnosis of FIV infection has shifted. Included in this review is our work investigating the performance of three commercially available FIV PoC test kits in FIV‐vaccinated cats and our recommendations for the diagnosis of FIV infection; the effect of primary FIV vaccination (three FIV vaccines, 4 weeks apart) on PoC test kit performance; our recommendations regarding annual testing of FIV‐vaccinated cats to detect ‘vaccine breakthroughs’; and the potential off‐label use of saliva for the diagnosis of FIV infection using some FIV PoC test kits. We also investigated the accuracy of the same three brands of test kits for feline leukaemia virus (FeLV) diagnosis, using both blood and saliva as diagnostic specimens. Based on these results, we discuss our recommendations for confirmatory testing when veterinarians are presented with a positive FeLV PoC test kit result. Finally, we conclude with our results from the largest and most recent FIV and FeLV seroprevalence study conducted in Australia to date. 相似文献
167.
168.
169.
170.